University of Strathclyde: Investment Portfolio & Startup News
University of Strathclyde
To add a bio or update investment portfolio click update information.
Investment Portfolio


Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
Mironid is a Glasgow-based biopharmaceutical company developing small molecule therapeutics for Autosomal Dominant Polycystic Kidney Disease, a life-threatening hereditary kidney disease with limited treatment options. Its first-in-class LoAc drug candidates target the abnormally high kidney cAMP levels that drive the uncontrolled growth of fluid-filled cysts.


Regeno secures £420k in funding from SFC and One Planet Capital for ground-level serviceable wind turbines
Regeno develops wind turbines that can be serviced from ground level to reduce installation and maintenance costs. Its design allows parts to be replaced without cranes or specialised offshore equipment, making wind energy more accessible for businesses and communities.


Sentinel secures £1.2m funding led by SFC Capital to expand its trauma support platform for frontline workers
Sentinel provides a digital platform for trauma prevention and support, designed with frontline workers to improve resilience, wellbeing and recovery in high-stress professions.
- 3(12 months)
- strath.ac.uk
More venture news
- 12 Nov 2026

GriffinGriffin closes a £15m Series B led by Octagon Partners to add cards and stablecoin payments to its banking platform
Series BFintech - 5 Nov 2026

T-TherapeuticsT-Therapeutics closes a £100m Series B led by Advent Life Sciences and British Business Bank to take its cancer and autoimmune treatments into clinical trials
Series BLife Sciences - 14 Oct 2026

Salience LabsSalience Labs lands a £95m Series B led by Bullhound Capital to boost AI datacentre connectivity with photonic chips
Series BDeep Tech